Senores Pharma IPO: The IPO of Senores Pharma, a drug manufacturing company associated with the pharmaceutical sector, opened on Friday, December 20. This IPO will close on Tuesday, December 24. Today, Monday, was the second day of this IPO. The company's IPO has received a great response from investors so far. Till 5 pm today, the company's IPO has received 13.88 times i.e. 1388 percent subscription.

The company wants to raise Rs 582.11 crore from IPO

Senores Pharma has fixed a price band of Rs 372 to Rs 391 per share under its IPO. The company wants to raise a total of Rs 582.11 crore through its IPO, for which a total of 1,48,87,723 shares will be issued.

Retail investors will have to invest at least Rs 14,858

In the IPO of Senores Pharma, 1,27,87,723 new shares worth Rs 500.00 crore with a face value of Rs 10 will be issued. Apart from this, the promoters of the company will issue 21,00,000 shares worth Rs 82.11 crore through OFS. To subscribe to this IPO, retail investors will have to invest at least Rs 14,858. For this money, they will be given 38 shares in one lot.

The company will be listed in the stock market on December 30

Let us tell you that after the IPO closes on Tuesday, the shares will be allotted on Thursday, December 26. Shares will be credited to the investors' demat accounts on Friday, December 27 and then finally the company will be listed on the stock market on Monday, December 30.

GMP price picked up pace

Senores Pharma's IPO is getting tremendous support from investors. Hence, the grey market is also witnessing a tremendous craze for the company's shares. On Monday, 23 December, Senores Pharma shares are trading with a premium of Rs 220 (56.27 per cent) in the grey market. However, its GMP price may fluctuate at the time of listing.